University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study.

Russell-Jones, D, Cuddihy, RM, Hanefeld, M, Kumar, A, González, JG, Chan, M, Wolka, AM, Boardman, MK and DURATION-4 Study Group, (2012) Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes Care, 35 (2). pp. 252-258.

Full text not available from this repository.

Abstract

To test the safety and efficacy of exenatide once weekly (EQW) compared with metformin (MET), pioglitazone (PIO), and sitagliptin (SITA) over 26 weeks, in suboptimally treated (diet and exercise) drug-naive patients with type 2 diabetes.

Item Type: Article
Authors :
NameEmailORCID
Russell-Jones, Ddavidrussell-jones@nhs.netUNSPECIFIED
Cuddihy, RMUNSPECIFIEDUNSPECIFIED
Hanefeld, MUNSPECIFIEDUNSPECIFIED
Kumar, AUNSPECIFIEDUNSPECIFIED
González, JGUNSPECIFIEDUNSPECIFIED
Chan, MUNSPECIFIEDUNSPECIFIED
Wolka, AMUNSPECIFIEDUNSPECIFIED
Boardman, MKUNSPECIFIEDUNSPECIFIED
DURATION-4 Study Group, UNSPECIFIEDUNSPECIFIED
Date : February 2012
Identification Number : https://doi.org/10.2337/dc11-1107
Uncontrolled Keywords : Diabetes Mellitus, Type 2, Double-Blind Method, Drug Administration Schedule, Female, Humans, Hypoglycemic Agents, Male, Metformin, Middle Aged, Peptides, Pyrazines, Thiazolidinediones, Treatment Outcome, Triazoles, Venoms
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 09:39
Last Modified : 17 May 2017 09:39
URI: http://epubs.surrey.ac.uk/id/eprint/824574

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800